18 results
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
19 Aug 20
Commercialiation Partnership Agreement
9:00am
Administration or any successor agency having the administrative authority to grant Marketing Approval in the United States.
“Field Action” means any recall … reported.
d. If any Governmental Authority mandates a recall or other Field Action in connection with the Products, or if Supplier determines
8-K
EX-1.1
ALBT
Avalon GloboCare Corp
26 Apr 19
Avalon GloboCare Announces $6 Million Registered Direct Offering with Institutional Investors
5:08pm
not, either voluntarily or involuntarily, initiated, conducted, or issued or caused to be initiated, conducted or issued, any recall, market withdrawal … the FDA or any other regulatory agency regarding, a material recall, market withdrawal or replacement of any Company product sold or intended
8-K
EX-10.1
ALBT
Avalon GloboCare Corp
26 Apr 19
Avalon GloboCare Announces $6 Million Registered Direct Offering with Institutional Investors
5:08pm
of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension
S-1
ALBT
Avalon GloboCare Corp
19 Feb 15
IPO registration
12:00am
that in the future a service liability claim or service recall could materially and adversely affect our business. Inability to obtain sufficient insurance coverage
S-3/A
f0pv36572i ts880ol
15 Jan 19
Shelf registration (amended)
3:31pm
424B5
ptr44z5l9ieufdwq3yd
13 Dec 19
Prospectus supplement for primary offering
5:07pm
S-3
2iu5p7d 8q
3 Jan 19
Shelf registration
12:00am
424B2
3f39g0qzg pldzaj1
26 Apr 19
Prospectus for primary offering
5:07pm
424B4
vegjweguhh13m9w9
14 Aug 18
Prospectus supplement with pricing info
12:18pm
- Prev
- 1
- Next